Want to see JP:4526 full AI Analyst Report?
Riken Vitamin Co., Ltd. (4526) Financial Statements
Riken Vitamin Co., Ltd. Financial Overview
Riken Vitamin Co., Ltd.'s market cap is currently $78.33B. The company's EPS TTM is $241.15; its P/E ratio is 14.24; and it has a dividend yield of 3.20%. Riken Vitamin Co., Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 96.30B | $ 95.58B | $ 91.48B | $ 88.75B | $ 79.23B |
| Gross Profit | $ 29.77B | $ 31.27B | $ 29.89B | $ 27.24B | $ 25.57B |
| Operating Income | $ 6.90B | $ 8.72B | $ 9.37B | $ 7.16B | $ 5.84B |
| EBITDA | $ 11.58B | $ 16.04B | $ 15.35B | $ 11.71B | $ 24.23B |
| Net Income | $ 7.04B | $ 9.39B | $ 8.76B | $ 6.41B | $ 21.58B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 20.07B | $ 22.30B | $ 23.38B | $ 19.16B | $ 17.30B |
| Total Assets | $ 116.39B | $ 113.00B | $ 118.78B | $ 105.22B | $ 102.66B |
| Total Debt | $ 7.14B | $ 9.98B | $ 16.09B | $ 14.60B | $ 17.57B |
| Net Debt | $ -12.93B | $ -12.32B | $ -7.30B | $ -4.56B | $ 270.00M |
| Total Liabilities | $ 33.01B | $ 33.80B | $ 42.13B | $ 33.85B | $ 36.12B |
| Stockholders' Equity | $ 83.34B | $ 79.16B | $ 76.61B | $ 71.34B | $ 66.52B |
| Cash Flow | |||||
| Free Cash Flow | $ 925.00M | $ 3.12B | $ 7.42B | $ 5.67B | $ 3.44B |
| Operating Cash Flow | $ 5.96B | $ 7.89B | $ 10.45B | $ 7.83B | $ 6.82B |
| Investing Cash Flow | $ 1.75B | $ 353.00M | $ -554.00M | $ -2.03B | $ -3.66B |
| Financing Cash Flow | $ -8.04B | $ -9.96B | $ -7.08B | $ -4.58B | $ -7.57B |
Currency in JPY